To verify the anti-hypertensive effect of DPP-4 inhibitor MK-626 in hypertension, we first measured the systolic blood pressure (sBP) before and after 2 weeks Ang II infusion with or without MK-626 treatment. This evidence concerns the gene DPP4 and Hypertension.